protein biomarkers
SeekIn Partners With OncoInv to Expand Global Accessibility of Cancer Detection Tests
SeekIn has granted OncoInv rights to market its tests in 12 countries, with the goal of improving access to early cancer detection and disease monitoring.
Vesper Bio Doses First Healthy Volunteer in Frontotemporal Dementia Therapy Trial
After establishing the safety of VES001 in healthy subjects, the company will conduct a proof-of-concept trial in FTD patients with GRN mutations.
Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection
Premium
Investigators are assessing performance in a prospective cohort with hopes that the method can be used to complement currently used imaging surveillance.
Octave Bioscience to Conduct Real-World Multiple Sclerosis Study Using Management Platform
The 150-patient, Biogen-sponsored study will use Octave's Precision Care Solution platform to better understand how MS progresses.
Using a protein biomarker signature, the company is advancing a CHK1/2 inhibitor that Eli Lilly out-licensed after seeing limited responses in genomic subgroups.